1. Fingolimod: risk of skin cancer and brain infection

   News item 17 October 2015 Pages: 1 - 1

2. MARC reviews statins-related interstitial lung disease

   News item 17 October 2015 Pages: 2 - 2

3. NZ MARC considers nitrofurantoin use with renal impairment

   News item 17 October 2015 Pages: 3 - 3

4. TGA rescheduling codeine products to prescription-only

   News item 17 October 2015 Pages: 4 - 4

5. UK and India regulators agree deal for collaboration

   News item 17 October 2015 Pages: 5 - 5

6. Empagliflozin raises the stakes in diabetes CV outcomes trials

   Meeting report 17 October 2015 Pages: 6 - 7

7. HPV vaccination syndrome: neuropathic pain, fibromyalgia

   Clinical study 17 October 2015 Pages: 7 - 7

8. Increased risk of suicide with β-blockers in elderly

   Clinical study 17 October 2015 Pages: 8 - 8

9. Increased risks of MACEs, all-cause mortality with β-blockers

   Unknown 17 October 2015 Pages: 9 - 9

10. Inhaled corticosteroid use in infants could stunt growth

    Clinical study 17 October 2015 Pages: 10 - 10

11. Link between SSRIs use and violent crime examined

    Epidemiology population study 17 October 2015 Pages: 11 - 11

12. Ocular gene therapy safe in elderly patients

    Clinical study 17 October 2015 Pages: 12 - 12

13. Safety of psoriasis therapies in Germany assessed

    Clinical study 17 October 2015 Pages: 13 - 13

14. Abacavir/atazanavir/lamivudine

    Case report 17 October 2015 Pages: 14 - 14

15. Abatacept

    Case report 17 October 2015 Pages: 15 - 15

16. Acitretin

    Case report 17 October 2015 Pages: 16 - 16

17. Adalimumab

    Case report 17 October 2015 Pages: 17 - 17

18. Adalimumab

    Case report 17 October 2015 Pages: 18 - 18

19. Adalimumab

    Case report 17 October 2015 Pages: 19 - 19

20. Adalimumab

    Case report 17 October 2015 Pages: 20 - 20

21. Adalimumab/etanercept/infliximab

    Case report 17 October 2015 Pages: 21 - 21

22. Adalimumab/infliximab

    Case report 17 October 2015 Pages: 22 - 22

23. Agomelatine/duloxetine interaction

    Case report 17 October 2015 Pages: 23 - 23

24. Alectinib

    Case report 17 October 2015 Pages: 24 - 24

25. Alemtuzumab/antithymocyte-globulin/methylprednisolone

    Case report 17 October 2015 Pages: 25 - 25

26. Alendronic acid/risedronic acid

    Case report 17 October 2015 Pages: 26 - 26

27. Alendronic-acid

    Case report 17 October 2015 Pages: 27 - 27

28. Ambrisentan

    Case report 17 October 2015 Pages: 28 - 28

29. Amiodarone

    Case report 17 October 2015 Pages: 29 - 29

30. Amiodarone

    Case report 17 October 2015 Pages: 30 - 30

31. Anakinra

    Case report 17 October 2015 Pages: 31 - 31

32. Anakinra/canakinumab/etanercept

    Case report 17 October 2015 Pages: 32 - 32

33. Anticoagulants/antiplatelets

    Case report 17 October 2015 Pages: 33 - 33

34. Antineoplastics

    Case report 17 October 2015 Pages: 34 - 34

35. Antiparkinsonians

    Case report 17 October 2015 Pages: 35 - 35

36. Antithymocyte globulin

    Case report 17 October 2015 Pages: 36 - 36

37. Antithymocyte globulin

    Case report 17 October 2015 Pages: 37 - 37

38. Antithymocyte globulin/corticosteroids

    Case report 17 October 2015 Pages: 38 - 38

39. Antithymocyte globulin/mycophenolic acid/prednisone/tacrolimus

    Case report 17 October 2015 Pages: 39 - 39

40. Antituberculars

    Case report 17 October 2015 Pages: 40 - 40

41. Aripiprazole

    Case report 17 October 2015 Pages: 41 - 41

42. Atazanavir/ritonavir

    Case report 17 October 2015 Pages: 42 - 42

43. Atomoxetine

    Case report 17 October 2015 Pages: 43 - 43

44. Atorvastatin

    Case report 17 October 2015 Pages: 44 - 44

45. Atracurium besilate

    Case report 17 October 2015 Pages: 45 - 45

46. Azathioprine/prednisolone

    Case report 17 October 2015 Pages: 46 - 46

47. Baclofen

    Case report 17 October 2015 Pages: 47 - 47

48. BCG vaccine

    Case report 17 October 2015 Pages: 48 - 48

49. BCG vaccine

    Case report 17 October 2015 Pages: 49 - 49

50. Bcg-vaccine

    Case report 17 October 2015 Pages: 50 - 50